Found: 59
Select item for more details and to access through your institution.
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1540, doi. 10.1002/ajh.27023
- By:
- Publication type:
- Article
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 413, doi. 10.1002/ajh.26806
- By:
- Publication type:
- Article
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 401, doi. 10.1002/ajh.26466
- By:
- Publication type:
- Article
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 267, doi. 10.1002/ajh.26439
- By:
- Publication type:
- Article
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. 209, doi. 10.1002/ajh.26422
- By:
- Publication type:
- Article
Prognostic significance of acquired 1q22 gain in multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 52, doi. 10.1002/ajh.26391
- By:
- Publication type:
- Article
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. 446, doi. 10.1002/ajh.26092
- By:
- Publication type:
- Article
Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first‐line therapy in multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 330, doi. 10.1002/ajh.26074
- By:
- Publication type:
- Article
Refining amyloid complete hematological response: Quantitative serum free light chains superior to ratio.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 11, p. 1280, doi. 10.1002/ajh.25940
- By:
- Publication type:
- Article
Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 637, doi. 10.1002/ajh.25773
- By:
- Publication type:
- Article
Implications and outcomes of MRD‐negative multiple myeloma patients with immunofixation positivity.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. E60, doi. 10.1002/ajh.25702
- By:
- Publication type:
- Article
Enhancing the R‐ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 310, doi. 10.1002/ajh.25709
- By:
- Publication type:
- Article
Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. E57, doi. 10.1002/ajh.25690
- By:
- Publication type:
- Article
Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. 751, doi. 10.1002/ajh.25481
- By:
- Publication type:
- Article
Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. 306, doi. 10.1002/ajh.25365
- By:
- Publication type:
- Article
Utility and prognostic value of <sup>18</sup>F‐FDG positron emission tomography‐computed tomography scans in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. 1518, doi. 10.1002/ajh.25279
- By:
- Publication type:
- Article
Serum free light chain measurements to reduce 24‐h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1207, doi. 10.1002/ajh.25215
- By:
- Publication type:
- Article
Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. 889, doi. 10.1002/ajh.25113
- By:
- Publication type:
- Article
Efficacy of VDT PACE‐like regimens in treatment of relapsed/refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 179, doi. 10.1002/ajh.24954
- By:
- Publication type:
- Article
Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 17, doi. 10.1002/ajh.24919
- By:
- Publication type:
- Article
Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. 1146, doi. 10.1002/ajh.24883
- By:
- Publication type:
- Article
Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 668, doi. 10.1002/ajh.24745
- By:
- Publication type:
- Article
Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. 549, doi. 10.1002/ajh.24723
- By:
- Publication type:
- Article
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 974, doi. 10.1634/theoncologist.2020-0388
- By:
- Publication type:
- Article
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01039-1
- By:
- Publication type:
- Article
Muscle and fat composition in patients with newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00934-3
- By:
- Publication type:
- Article
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00957-w
- By:
- Publication type:
- Article
MM-431: A Comparison Between Daratumumab and Non-Daratumumab-Based Salvage Regimens Used at First Relapse Post-Lenalidomide Maintenance in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S444, doi. 10.1016/S2152-2650(21)01987-X
- By:
- Publication type:
- Article
MM-429: Impact of Prolonged Lenalidomide Maintenance (≥3 years) and Outcomes in Patients with Multiple Myeloma Post-Autologous Stem Cell Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S443, doi. 10.1016/S2152-2650(21)01986-8
- By:
- Publication type:
- Article
MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S435, doi. 10.1016/S2152-2650(21)01970-4
- By:
- Publication type:
- Article
Poster: MM-431: A Comparison Between Daratumumab and Non-Daratumumab-Based Salvage Regimens Used at First Relapse Post-Lenalidomide Maintenance in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S256, doi. 10.1016/S2152-2650(21)01611-6
- By:
- Publication type:
- Article
Poster: MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S255, doi. 10.1016/S2152-2650(21)01605-0
- By:
- Publication type:
- Article
Poster: MM-429: Impact of Prolonged Lenalidomide Maintenance (≥3 years) and Outcomes in Patients with Multiple Myeloma Post-Autologous Stem Cell Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S252, doi. 10.1016/S2152-2650(21)01580-9
- By:
- Publication type:
- Article
The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 7, p. 451, doi. 10.1016/j.clml.2021.02.001
- By:
- Publication type:
- Article
Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pilot study of Ixazomib, Lenalidomide, and Dexamethasone for Patients with POEMS Syndrome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e311, doi. 10.1016/j.clml.2019.09.512
- By:
- Publication type:
- Article
Blood mass spectrometry Detects Residual Disease Better than Standard Techniques in Immunoglobulin light chain amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e313, doi. 10.1016/j.clml.2019.09.514
- By:
- Publication type:
- Article
Outcomes with different administration schedules of VRD as first-line therapy in multiple myeloma: a retrospective analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e203, doi. 10.1016/j.clml.2019.09.338
- By:
- Publication type:
- Article
Predictors of Early Treatment Failure following initial therapy for Systemic Immunoglobulin Light Chain Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e83, doi. 10.1016/j.clml.2017.03.150
- By:
- Publication type:
- Article
Bortezomib Versus Non-Bortezomib Based Initial Treatment for Transplant Ineligible Patients with Light Chain Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e140, doi. 10.1016/j.clml.2017.03.254
- By:
- Publication type:
- Article
Natural History of t(11;14) Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e20, doi. 10.1016/j.clml.2017.03.034
- By:
- Publication type:
- Article
Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00785-y
- By:
- Publication type:
- Article
A simple additive staging system for newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00611-x
- By:
- Publication type:
- Article
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM).
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00548-7
- By:
- Publication type:
- Article
Correction: MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00444-0
- By:
- Publication type:
- Article
Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 12, p. 1, doi. 10.1038/s41408-020-00391-2
- By:
- Publication type:
- Article
Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00353-8
- By:
- Publication type:
- Article
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00348-5
- By:
- Publication type:
- Article
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 5, p. 1, doi. 10.1038/s41408-020-0319-0
- By:
- Publication type:
- Article